Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)

David H. Birnie, Jeff S. Healey, George A. Wells, Felix Ayala-Paredes, Benoit Coutu, Glen L. Sumner, Giuliano Becker, Atul Verma, François Philippon, Eli Kalfon, John Eikelboom, Roopinder K. Sandhu, Pablo B. Nery, Nicholas Lellouche, Stuart J. Connolly, John Sapp, Vidal Essebag